Login / Signup

Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Ji Eun JunIn-Kyung JeongJae Myung YuSung Rae KimIn Kye LeeKyung Ah HanSung Hee ChoiSoo Kyung KimHyeong Kyu ParkJi Oh MokYong Ho LeeHyuk Sang KwonSo Hun KimHo Cheol KangSang Ah LeeChang Beom LeeKyung Mook ChoiSung Ho HerWon Yong ShinMi Seung ShinHyo Suk AhnSeung Ho KangJin Man ChoSang Ho JoTae Joon ChaSeok Yeon KimKyung Heon WonDong Bin KimJae Hyuk LeeMoon Kyu Lee
Published in: Diabetes & metabolism journal (2019)
The addition of OM3-FAs to atorvastatin improved TG and non-HDL-C levels to a significant extent compared to atorvastatin alone in subjects with residual hypertriglyceridemia.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • fatty acid
  • phase iii
  • study protocol
  • cardiovascular disease
  • phase ii study
  • open label
  • randomized controlled trial
  • type diabetes
  • squamous cell carcinoma